BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25558698)

  • 1. CA125 expression in the tissue of uterine leiomyosarcoma.
    Menczer J; Schreiber L; Berger E; Ben-Shem E; Golan A; Levy T
    Isr Med Assoc J; 2014 Nov; 16(11):697-9. PubMed ID: 25558698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
    Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
    Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
    Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
    Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA125.
    Holcomb K; Francis M; Ruiz J; Abulafia O; Matthews RP; Lee YC
    Gynecol Oncol; 1999 Sep; 74(3):499-501. PubMed ID: 10479519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis: positive correlation between serum CA125 level and endometriotic epithelial cell proliferation.
    Toki T; Kubota J; Lu X; Nakayama K
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):771-6. PubMed ID: 10993101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
    Bodner-Adler B; Nather A; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2006 Oct; 103(1):186-9. PubMed ID: 16595146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K; Lozanov P; Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Reprod Med; 2003 Feb; 48(2):95-100. PubMed ID: 12621792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of CA125 immunohistochemical staining in patients with ovarian cancer].
    Adachi S; Noda T; Kiyozuka Y; Ito K; Itani Y; Tsujimoto A; Sakakura S; Yoshida T; Umekage H; Nakayama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Sep; 46(9):896-902. PubMed ID: 7963890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
    Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B; Bodner K; Kimberger O; Czerwenka K; Leodolter S; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study.
    Høgdall EV; Christensen L; Kjaer SK; Blaakaer J; Kjaerbye-Thygesen A; Gayther S; Jacobs IJ; Høgdall CK
    Gynecol Oncol; 2007 Mar; 104(3):508-15. PubMed ID: 17113137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
    Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
    Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
    Bodner-Adler B; Bodner K; Czerwenka K; Kimberger O; Leodolter S; Mayerhofer K
    Gynecol Oncol; 2005 Jan; 96(1):62-6. PubMed ID: 15589581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is tissue CA125 expression in epithelial ovarian adenocarcinoma heterogenic?
    Sparholt MH; Høgdall CK; Nedergaard L; Heeran MC; Christensen IJ; Høgdall EV
    APMIS; 2013 Jan; 121(1):38-44. PubMed ID: 23030299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of serum CA19-9, CA125 and CP2 in mucinous ovarian tumor: a retrospective study of 273 patients].
    Dong L; Cui H; Li XP; Sun LF; Chang XH; Liang XD; Zhu HL
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):5-8. PubMed ID: 18366923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.